• To identify patients at risk for immediate-type allergic reactions to streptokinase, we performed streptokinase skin tests on patients immediately before planned administration of intravenous streptokinase for treatment of acute myocardial infarction. Forty-five patients had negative skin tests and received streptokinase without allergic reaction. One patient had a positive skin test and was given urokinase instead, without incident. Positive skin tests were also present in a patient who had recently had an anaphylactic reaction to streptokinase, and in two physician volunteers who had been sensitized to streptokinase during initial determination of the optimal skin testing dose. Immunoassays for IgE to streptokinase were performed on serum samples from skin-tested patients and volunteers, and on 16 other patients who had not been skin tested but had previously received streptokinase without allergic reactions. The skin test was a sensitive and specific indicator of elevated levels of IgE to streptokinase. We propose that skin testing immediately before streptokinase administration is a practical approach for identifying patients at risk for immediate-type allergic reactions to streptokinase, and its use may possibly prevent anaphylaxis and death.
(Arch Intern Med 1986;146:305-307)
Dykewicz MS, Kris G., Davison R, Kaplan KJ, Patterson R. Identification of Patients at Risk for Anaphylaxis due to Streptokinase. Arch Intern Med. 1986;146(2):305–307. doi:10.1001/archinte.1986.00360140127018
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: